Tonix Pharmaceuticals Holding Corp. (TNXP)
19.63
-0.12
(-0.61%)
USD |
NASDAQ |
Dec 11, 16:00
19.58
-0.05
(-0.25%)
After-Hours: 20:00
Tonix Pharmaceuticals Cash from Investing (Quarterly): -1.029M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Amicus Therapeutics, Inc. | -1.299M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
| Soligenix, Inc. | -0.0006M |
| GeoVax Labs, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.47M |
| Cash from Financing (Quarterly) | 100.12M |
| Free Cash Flow | -78.87M |
| Free Cash Flow Per Share (Quarterly) | -3.528 |
| Free Cash Flow to Equity (Quarterly) | -31.42M |
| Free Cash Flow to Firm (Quarterly) | -31.48M |
| Free Cash Flow Yield | -72.39% |